2022 Pharmacotherapy Lecture Series | Antiemesis: A comparison of Treatment Approach between NCCN and ASCO Guidelines
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Diana Van Ostran, PharmD, BCOP
Disclosure
Diana Van Ostran, PharmD, BCOP discloses no such relationships exist
Accreditation
NA
Related Courses
2025 SPS Puerto Rico | Infliximab Intravenous vs. Subcutaneous: Clinical and Practice Considerations
0.00 AMA PRA Category 1 Credits™
1 Chapter
Pharmacological
Free
2025 SPS Puerto Rico | An Expanding Bispecifics Armamentarium: Zanidatamab Clinical Review and Considerations
0.00 AMA PRA Category 1 Credits™
1 Chapter
Pharmacological
Free